Abstract
Seasonal variation in the age distribution of influenza A cases suggests that factors other than age shape susceptibility to infection. Here, we ask whether these differences can be explained in part by protection conferred by childhood influenza infection, which has lasting impacts on immune responses to influenza and protection against novel influenza A subtypes (phenomena known as original antigenic sin and immune imprinting). Fitting a statistical model to 11 years of data from studies of influenza vaccine effectiveness (VE) in Marshfield, Wisconsin, we find that primary infection appears to reduce the risk of medically attended infection with that subtype throughout life and shapes the distribution of seasonal influenza A cases. This effect is particularly strong for H1N1 (66% reduction in medically attended H1N1 infection risk, CI 53-77%) compared to H3N2 (33% reduction in medically attended H3N2 infection risk, CI 17-46%). Additionally, we find evidence that influenza VE varies with both age and birth year, but not with the imprinting subtype per se. This suggests that VE may be sensitive to particular exposure histories. The ability to predict age-specific risk might improve forecasting models and vaccination strategies to combat seasonal influenza.
Competing Interest Statement
The authors report grants from National Institutes of Health and grants from Centers for Disease Control during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Statement
Funding for this project was provided by the National Institutes of Health (NIH), Department of Health and Human Services, under grant DP2AI117921 (to SC) and CEIRS Contract No. HHSN272201400005C (to SC). Centers for Disease Control (CDC) provided funding to Marshfield Clinic Research Institute for original enrollment and data collection to estimate effectiveness (U01IP001038, U01IP000471, U01IP000471, U01CI000192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
Data for this study are available at www.github.com/cobeylab/FluAImprinting
